Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Takara Bio Inc banner

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 147 JPY -0.09% Market Closed
Market Cap: ¥138.1B
Write Note Create Alert Ask AI

Takara Bio Inc
Investor Relations

Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,539 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Show more
Loading
4974
Nikkei 225
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Koichi Nakao
CEO, President & Representative Director
No Bio Available
Dr. Yoh Hamaoka Ph.D.
CFO, Senior Executive Officer & Director
No Bio Available
Mr. Takuya Kakemi
Executive Officer, Deputy GM of Corporate Headquarters & GM of Public Relations and IR Department
No Bio Available
Akira Kodera
Managing Executive Officer & Head of Sales Division
No Bio Available
Noritaka Nishiwaki
Executive Officer, Deputy GM of Corporate Headquarters & GM of Human Resources Department
No Bio Available
Mr. Tsuyoshi Miyamura
Senior Managing Director & Director
No Bio Available
Mr. Junichi Mineno Ph.D.
VP, Executive Officer & Director
No Bio Available
Mr. Katsuhiko Kusakabe
CMCO, Senior Executive Officer & Director
No Bio Available
Mr. Andrew Farmer Ph.d.
Head of Research and Development
No Bio Available
Kyoko Nakajima
Managing Executive Officer & Head of SCM Division
No Bio Available

Contacts

Address
SHIGA-KEN
Kusatsu-shi
7-4-38, Noji-Higashi
Contacts
+81775656920.0
www.takara-bio.co.jp
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.